Oncology Sponsored Oncology in the NHS: Situations, challenges, and solutions Oncology is a singularly complex healthcare area.
Views & Analysis The changing frontline: how to engage with England’s NHS in ... Wilmington Healthcare-pharmaphorum conference: England’s NHS is moving towards integrated care, and long-term outcomes-based contracts for medicines could become the norm
Views & Analysis Manchester setting the pace in NHS move to outcomes-based de... The NHS is moving rapidly towards integrated care models – and outcomes-based deals with pharma will also play a role.
Views & Analysis The NHS, new models of care and STPs: what role for pharma? These are challenging times in the NHS, with reforms and budget restrictions putting the health service under huge strain.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
